Diferencia entre revisiones de «Taubenberger»
| Línea 4: | Línea 4: | ||
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA *Corresponding author: Tel: +1 301 443 5960; Fax: +1 301 480 5722; E-mail: taubenbergerj@niaid.nih.gov | National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA *Corresponding author: Tel: +1 301 443 5960; Fax: +1 301 480 5722; E-mail: taubenbergerj@niaid.nih.gov | ||
| + | |||
| + | Trata tres temas: | ||
| + | 1) alleged discovery of a bacterial cause of influenza during the 1889–1893 pandemic, | ||
| + | |||
| + | 2) the controversial detection of ‘filter-passing agents’ during the 1918–1919 pandemic, | ||
| + | |||
| + | 3) and subsequent breakthroughs in the 1930s that led to isolation of human and swine influenza viruses | ||
(Volver a [[Fuentes]]. [[Cronología]]. [[Personas]].) | (Volver a [[Fuentes]]. [[Cronología]]. [[Personas]].) | ||
Revisión del 15:40 15 oct 2016
Jeffery K Taubenberger (Volver a Personas. Cronología. Fuentes.)
Autor junto con Johan V Hultin y David M Morens de: Discovery and characterization of the 1918 pandemic influenza virus in historical context.
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA *Corresponding author: Tel: +1 301 443 5960; Fax: +1 301 480 5722; E-mail: taubenbergerj@niaid.nih.gov
Trata tres temas: 1) alleged discovery of a bacterial cause of influenza during the 1889–1893 pandemic,
2) the controversial detection of ‘filter-passing agents’ during the 1918–1919 pandemic,
3) and subsequent breakthroughs in the 1930s that led to isolation of human and swine influenza viruses
(Volver a Fuentes. Cronología. Personas.)
